DAFTAR PUSTAKA

Anonim1, 2002, National Kidney Foundation-Kidney Disease Outcome Quality Initiative

(NKF-KDOQI), KDOQI Clinical Practice Guideliner for Chronic Kidney
Disease: Evaluation, Classification, and Stratification,
http://www.kidney.org/professionals/KDOQI/guidelines_ckd/p4_class_g1.htm,
30 Agustus 2013.

Anonim2, 2006, Treatment Methods for Kidney Failure: Hemodialysis, NIDDK

(National Institute of Diabetes and Digestive and Kidney Disease),
http://www.kidney.niddk.nih.gov, 30 Agustus 2013.

Anonim3, 2007, Hemodialysis: What You Need to Know dalam National Kidney
Foundation Booklet, 11-50-0214, National Kidney Foundation, Inc., New
York.

Anonim4, 2008, Diagnosis and Management of Chronic Kidney Disease: A National

Clinical Guideline, SIGN (Scottish Intercollegiate Guideline Network), 106,
15-28.

Anonim5, 2010, The National Kidney and Urologic Diseases Information Clearinghouse
(NKUDIC), http://www.kidney.niddk.nih.gov, 30 Agustus 2013.

Anonim6, 2013, Rumah Sakit Akademik UGM Yogyakarta, http://rsa.ugm.ac.id/

Anonim7, 2013, http://www.renalmed.co.uk, diakses pada 28 Oktober 2013.

Anonim8, 2013, http://www.aafp.org/, diakses pada 10 November 2013.

Block ,G, A., Klassen ,P, S., Lazarus ,J, M., Ofsthun ,N., Lowrie E,G., Chertow, G, M., 2004,
Mineral metabolism, mortality, and morbidity in maintenance hemodialysis, J
Am Soc Nephrol;15:2208-18.

Brunner, L., Suddarth, D., 2002, Buku Ajar Keperawatan Medical Bedah (H. Kuncara, A.
Hartono, M. Ester, Y. Asih, Terjemahan), Edisi 8, Vol 1, Jakarta, EGC.

Chen, H, Hsu., 1999, New Phosphate Binding Agents: Ferric Compounds, J Am Soc Nephrol
10: 1274 –1280.

Coladonato, Joseph, A., 2005, Control of Hyperphosphatemia among Patients with ESRD,
Carolina Kidney Associates, Greensboro, North Carolina, J Am Soc Nephrol 16:
S107–S114.

Departemen Kesehatan RI, 2007, Profil Kesehatan Indonesia 2007, Jakarta :Departemen
Kesdata.

Faris, Muhammad., 2003, Hubungan antara kadar hormon paratiroid dengan kalsium dan
fosfat pada penderita hemodialisis kronik, Yogyakarta.

63
Ferreira, Anibal., Frazao, Miguel., Gil, Celia., 2008, Effects of Sevelamer Hydrochloride and
CalciumCarbonate on Renal Osteodystrophy in Hemodialysis Patients, J Am Soc
Nephrol 19: 405–412, 2008.

Finn, William, F., 2005, Phosphorus Binders: Relative Potency: Phosphate-Binding Agents,
Medscape Nephrology, 2 (1), dalam
http://www.medscape.org/viewarticle/506489_3

Harvey, A, Jean., Zobitz, M, Margaret., Pak, Charles., 2009, Dose dependency of calcium
absorption: A comparison of calcium carbonate and calcium citrate, dalam:
http://www.ncbi.nlm.nih.gov/pubmed/3213620, diakses pada 14 November 2013.

Hellman, P., 2009, Correlation between plasma calcium, parathyroid hormone (PTH) and the
metabolic syndrome (MetS) in a community-based cohort of men and women,
Pubmed, Clin Endocrinol (Oxf), Nov;71(5):673-8

Herawati, 2009, Mengenal Anemia dan Peranan Erythropoietin, BioTrends /Vol.4/No.1/T

ahun 2009, Jakarta.

Hudson, J.Q., 2008, Chronic Kidney Disease: Management of Complications, dalam

Dipiro, J.T., Wells, B.G., Schwinghammer, T.L., Dipiro, C.V.,
Pharmacotherapy: A Pathophysiologic Approach 7th Ed., McGrawHill, United
Stated.

Hutchison, Alastair, J., 2011, Pharmacology, Efficacy, and Safety of Oral Phosphate Binders:
Pharmacology of Oral Phosphate Binders, Nat Rev Nephrol. 2011;7(10):1-12,
dalam http://www.medscape.org/viewarticle/748910_7

Indridason, Olafur, S., 2000, Comparison of treatments for mild secondary

hyperparathyroidism in hemodialysis patients, Kidney International (2000) 57,
282–292; doi:10.1046/j.1523-1755.2000.00819

Jorde, Rolf., Sundsfjord, Johan., Haug, Egil, 2010, Relation Between Low Calcium Intake,
Parathyroid Hormone, and Blood Pressure, Ahajournals, Hypertension. 2000;
35: 1154-1159

Joy, M.S., Kshirsagar, A., Franceschini, N., 2008, Chronic Kidney Disease:
Progression-Modifying Therapies, dalam Dipiro, J.T., Wells, B.G.,
Schwinghammer, T.L., Dipiro, C.V., Pharmacotherapy: A Pathophysiologic
Approach 7th Ed., McGrawHill, United Stated.

Klag, M.J., Whelton, P.K., Randall, B.L., Neaton, J.D., Brancati, F.L., Ford, C.E., Shulman,
N.B., Stamler, J., 1996, Blood Preasure and End-Stage Renal Disease in
Men, Jurnal Penelitian, The New England Journal of Medicine.

Larry, J., 2008, Merck Manual Home Health Handbook.

Lee,W, P., 2002, Correlations among serum calcium, vitamin D and parathyroid hormone
levels in the elderly in southern Taiwan, Pubmed, J Nurs Res, Mar;10(1):65-72.

64
Erwinsyah, 2011, Peran Sulfas Ferrosus Sebagai Pengikat Fosfat (Phosphate Binder) Pada
Pasien Pgk Dengan Hemodialisis Reguler, Universitas Sumatera Utara.

Fox, C.H., Voleti, V., Khan, L.S., Murray, B., Vassalotti, J., 2008, A Quick Guide to
Evidence-Based Chronic Kidney Disease Care for the Primary Care
Physician, Postgraduate Medicine, 120 (2), 1-6.

Nasution, M.Y., Prodjosudjadi, W., 2001, Pemeriksaan Penunjang pada Penyakit Ginjal,
dalam Buku Ajar Ilmu Penyakit Dalam, Ed. III, hal 299-306, Balai Penerbit
FKUI, Jakarta.

Notopoero, P, B., 2005, Eritropoitin Fisiologi, Aspek Klinik, Dan Laboratorik, Jakarta.

Octawati, Ita., 2005, Profil kadar hormon Paratiroid, Kalsium dan Fosfat pada pasien gagal
ginjal kronik yang menjalani Hemodialisis di RS Dr. Sardjito Yogyakarta,
Yogyakarta.

Palmer, B.F., 1999, Dialisate Composition in Hemodialysis and Peritoneal Dialysis,

dalam William, L.H (Ed), Principles and Practice of Dialysis, Edisi II, 22-40,
Williams & Wilkins, Baltimore.

Pranawa, Y., Irawanadi, C.M., Santoso, D.,Mardiana, N., Thaha, M., Widodo, S., 2007,
Penyakit Ginjal Kronis dalam Buku Ajar Ilmu Penyakit Dalam, 221-229,
Fakultas Kedokteran UNAIR-RSP Dr. Soetomo, Surabaya.

Rumahorbor, Hotma., 1999, Asuhan Keperawatan Klien dengan Gangguan Sistem Endokrin,
Jakarta:EGC.

Saif, Imran., Halim, Abdul., Altaf, Ashfaq., 2007, Comparison Of Calcium Acetate With
Calcium Carbonate As Phosphate Binder In Patients On Maintenance
Haemodialysis, J Ayub Med Coll Abbottabad;19(4).

Siregar, C.J.P., dan Amalia, L., 2003, Farmasi Rumah Sakit : Teori dan Penerapan, 5, Edisi
Pertama, 54-57, EGC, Jakarta.

Soegondo, S., Soewondo, P., Soebekti, 2005, Penatalaksanaan Diabetes Mellitus Terpadu,
112-118, Penerbit Fakultas Kedokteran UI, Jakarta

Stevens, L.A., University School of Medicine, St. Louis, Missouri, USA. Coresh, J.,
Greene, T., Levey, A.S., 2006, Assessing Kidney Function-Measured and
Estimated Glomerular Filtration Rate, N Engl J Med, 354, 2473-2483.

Slatapolsky1, E., Weerts, C., Lopez-Hilker, S., 1986, Calcium carbonate as a phosphate
binder in patients with chronic renal failure undergoing dialysis, N Engl J Med.
1986;315:157-161.

Slatopolsky2, E., Brown, A., Dusso, A., 1999, Pathogenesis of secondary

hyperparathyroidism, Washington.

65
Slinin, Y., Foley ,R, N., Collins ,A, J., 2005, Calcium, phosphorus, parathyroid hormone,
and cardiovascular disease in hemodialysis patients: the USRDS, Waves 1, 3,
and 4 Study, J Am Soc Nephrol 16:1788-93.

Sudoyo, W, Aru., ,2009, Penyakit Ginjal Kronik Jilid 3 Edisi V, Buku Ajar Ilmu Penyakit
Dalam, Jakarta : Interna Publishing.

Suwitra, K., 2006, Peran gangguan fosfat dan kalsium pada morbiditas dan mortalitas
penyakit ginjal kronik, dalam : “Peranan stres oksidatif dan pengendalian resiko
pada progresif Penyakit ginjal kronik serta Hipertensi”, JNHC (Jakarta
Nephrology and Hypertension Course).

Sja’bani, M., 1995, Terapi Konservatif pada Gagal Ginjal Kronik, Berkala Ilmu Kedokteran,
27 (2), 103-108.

Tomasello, Sarah., 2008, Secondary Hyperparathyroidism and Chronic Kidney Disease,

Diabetes Spectrum Volume 21, Number 1.

Tom, A., McCauley, L., Bell, L., Rodd, C., Espinosa, P., Yu, G., Yu, J., Girardin, C., Sharma,
A., 1999, Growth during maintenance hemodialysis: impact of enhanced
nutrition and clearance, J Pediatr 134:464-471, 1999

Pradeep, Arora., 2010, Chronik Renal Failure: Nephrology (serial online) 4 Februari 2010,
http://emedicine.com, diakses: 26 Maret 2014.

Putra, Christian, Kurnia., 2012, Analisis Biaya Terapi Pasien Hemodialisis Reguler Gagal
Ginjal Kronis Tahap Akhir Rawat Jalan Di Rumah Sakit Pku Muhammadiyah
Yogyakarta Tahun 2010, Yogyakarta.

Qin, X., Huo, Y., Langman, C.B., Hou, F., Chen, Y., Matossian, D., Xu, X., Wang, X.,
2011, Folic Acid Therapy and Cardiovascular Disease in ESRD or Advanced
Chronic Kidney Disease: A Meta-Analysis, Clin J Am Soc Neprol, 6, 482-
488.

66